中国生物制药：截至二零二四年十二月三十一日止年度业绩公告

www.sinobiopharm.com1177 1 2 3 4 5 20002013MSCI201820205025TOP5050 E GMPPVCGMP invoX Pharma LimitedinvoX GMP GMPCN20110001 MSCI 50 50 Top50 http://www.sinobiopharm.com 2024202425,298.53,420.71.1% 202451420242024109 202427 2018104357530 20241%1 6NMPA41202412024120.621.9%28NMPA202420245100.925.4% –CDECDEIIIIII –G-CSFIIIFcPEGPEG2023122024 –PD-L120244NMPA11NMPAMSI-HdMMRIIIETER701mPFS6.9mOS19.3Nature MedicineCDECDE –ROS1/ALK/c-Met20244NMPAROS1ROS1IIROS12024 –ALK20246NMPAALKALKIIIALK2024 –KRAS G12C202411NMPAKRAS G12CIIKRAS G12CORR52.0%mPFS9.1mOS14.1KRAS G12COS20246CDE1KRAS G12C2KRAS G12CKRAS G12CII –202322023520237202412NMPACD20BHER2HER22024 –3638III11II14I14621I5BE2025-202768 –TQB3616CDK2/4/620247CDEHRHER2TQB3616CDK2/4/6TQB3616CDK2CDK4CDK4/62024CSCOTQB3616HRHER2IIIORR40.21%mPFS 16.62mOSTQB3616HRHER2IIITQB3616TQB3616 –TQ05105JAK/ROCK20247CDEJAK/ROCK2024ASHTQ05105IbIb/IIaITQ05105 –LM-108CCR8ADCCCCR8IIPD-1PD-1/PD-L1MSI-H/dMMRLM-108TTregTregLM-108 –M701CD3/EpCAMCD3/EpCAMIIIM701EpCAMTCD3TTM701 –FS222CD137PD-L1I2024ASCOFS222IFS222MSSPD-1ORR47.4%DCR68.4%FS222 –399.9%20232024APASLEASL –71III6II732111BE2025-202715 –PPARIIIMASHF1F3MASHIIbNEJMPPARPPAR/PPARPPAR20237CDEIIIMASH –TQA2225FGF21-FcFGF21MASHIITQA2225FGF21FGF21MASHTQA2225FGF21 –2024 –E2021E2023E202120192024 –112III5II4I13621I4BE2025-202728 –TQC2731TSLPTSLPIIITSLPTSLPTSLPTQC2731 –TDI01ROCK2ROCK2IITDI01ROCK2TDI01II2025IIITDI01 –TQC3721PDE3/4PDE3/4IIPDE3PDE4TQC3721TQC3721PDE3/4 –TCR1672P2X3RP2X3Ib/II2021TCR1672FDAINDP2X3TCR1672P2X3P2X2/3P2X3TCR1672P2X3 –TQH2722IL-4RIL-4RIIITQH2722IL-4IL-1322 –20242025 –621III2II1I8622025-202748 –PL-5202412CDEPL-5PL-5 –TRD205AT2RAT2RFirst-in-ClassIITRD205AT2RTRD205<15%TRD205 –TRD303IITRD303TRD30372TRD303TRD303 –20243 212023 –20243 282024 PMCTOP15TOP15 –20246 2520242023TOP100 –20246 30ESGESG100 –20247 16S&P GlobalSustainable120242024 –20248 1020242024 –20249 72023 –20249 11E100 –20249 262024ESG10ESG –202411 13TOP100ESGTOP20TOP1012015-2030TOP20 –202412 1412024 –202412 162024 2,886,61610.2%2,619,9412,352,99410.9%2,120,9532,345,00011.0%2,112,4857,9945.6%8,468 349,98350.1%19.1351.9%345,69633.5% 956,958936,581517,1472,410,686 5181,972170,96093%26% 158,01348,476 7 1,073,36337.2%22.0% 343,79511.9%10.1% 315,17110.9%6.2% 445,81715.4%18.9% 216,9227.5%21.0% 4 9 1 , 5 4 817.1%19.6% 33.5% *invoX 15.03%/57,883 11,83010,828 11,091,153156,287957,90014.6%27,68630,108 443,911469,970495,083281,19686,17555,20050,51446,90034,15133,72633,00830,80025,000495,08322,064155,32622,064517,1477.9% 14.225%14 920 70397136565 548,76719.0%92.7%508,92017.6%77%17.2% 1,0693495,0821,958 2024328202320248132024 800 956,958945,188936,581731,289 758,5831,113,594199,675105,7941,6241,64811,17336,988394382300260 45,939149,400 6,540,8076,360,4822,263,4002,543,48734.6%40.0%1,439,631854,975 24,379467,056435,303 268,476,600310108,384,000528,366,443338,690,000 ESG ESG 2024+ESG2024ESGESGESG ESGAIDeepSeek-R1ESGESG DAYESG ESG202442023ESGESGBDOESG 2024-20252024 ESGESGPSCIESG96%13100% 6,0113,213 ESG2024MSCI ESGACSA4%2025FTSE4Good‘ESG100’2024 ESGESG2024 20251 2024420273050% A IDeepSeekChatGPTAIAIAI 2025 6,364,6825,097,398 170,227(70,564)145,13146,023 315,358(24,541) (110,268)114,528 205,09089,987 6,569,7725,187,385 6,569,7725,187,385 7 7 5,128,8411,198,756 1. 1.1 (a) (b) (c) 1.2 117716 1.3 21197218319310284 1234 2. (a) (b) (c) 5,609,184(258,469)76,0705,426,785 5,277,468(492,918) 1,620,085516,288 25,771,303–428,10626,199,409 6,525,182(405,888)19,8786,139,172 1,053,414238,859 (a) 90% 10% 3. 4. 5. **** 6. 16.5%16.5% 25%19%-25% 25% 20081 125% 10%5%10% 20241231 2025630 7. 181,972170,96093%26% *20232024 1,574,204– 1,580,132225,207 #20243 8. 0.030.027670.020.017150.040.037600.030.02726 43 (a)1617 (b)1617 9. 3,499,834,0002,331,939,00018,293,510,73418,529,064,920 20241231 2024 10. 090 9091180180 12. 9091180180 13. 18,791,217,2300.02518,801,217,2300.025 14. 378,335,000 C1C.1.6 3.103.10A 10,000,00024,382,000 254,183,00082,750,000 1,075,827,000338,690,000